Bluejay Diagnostics amends 2021 stock plan, approved by shareholders June 9, 2026
The company's Board approved Amendment No. 1 to its 2021 Stock Plan on April 28, 2026, with stockholder approval on June 9, 2026. The amendment modifies the equity compensation framework for key employees, directors, and consultants.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day